Becton, Dickinson and Co. | BDX - Des Atouts





Des Atouts Changement Date
Abbott USD 110.43B 23.72B 2026-03
Agilent USD 13.07B 252M 2026-03
Align Technology USD 6.42B 103.41M 2026-06
AngioDynamics USD 269.68M 4.04M 2025-09
Baxter International USD 19.79B 55M 2026-06
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Bio-Rad Laboratories USD 10.25B 462M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
Cooper Companies USD 12.48B 58.1M 2026-03
Danaher USD 92.37B 8.82B 2026-06
Dentsply International USD 5.2B 25M 2026-06
Dexcom USD 6.46B 178M 2026-06
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.56B 14.24M 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
J&J USD 201.06B 167M 2026-06
Medtronic USD 91.48B 139M 2025-12
Solventum Corp USD 14.24B 146M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Terumo JPY 2.37T 61.86B 2026-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06